IP Library › Patent Application 10633233
Patent Application
App. No. 10/633,233

Weight control compositions and methods

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/633,233
Abstract

The present invention provides compositions and methods that assist in providing weight control. Compositions comprise Caffeine, an adrenergic amine (e.g. synephrine, hordenine, octopamine, tyramine and N-methyltyramine,) forskolin, Guggulsterones, an alpha-2 receptor antagonist (e.g. Yohimbine) and a vinca alkaloid (e.g. vinpocetine.) Black pepper extract may be added as well in various alternative embodiments. Methods utilizing administration of nutrient compositions are disclosed as well.

Claims (39)

2 ) A method for weight control in a mammal, comprising administration of a composition comprising: Caffeine, Adrenergic Amine, Forskolin, Guggulsterone, Alpha-2 Receptor Antagonist, and Vinca Alkaloid.

3 ) A method as in claim 1 further comprising Black Pepper Extract.

4 ) A method as in claim 1 wherein said Adrenergic Amine is selected from the group consisting of Synephrine, Hordenine, Octopamine, Tyramine And N-Methyltyramine.

5 ) A method as in claim 1 wherein said Alpha-2 Receptor Antagonist is Yohimbine.

6 ) A method as in claim 1 wherein said Vinca Alkaloid is Vinpocetine.

7 ) A method as in claim 1 wherein said administration comprises a therapeutically effective dosage.

8 ) A composition comprising Caffeine, Adrenergic Amine, Forskolin, Guggulsterone, Alpha-2 Receptor Antagonist, and Vinca Alkaloid.

9 ) A composition as in claim 7 further comprising Black Pepper Extract.

10 ) A composition as in claim 7 wherein said Adrenergic Amine is selected from the group consisting of Synephrine, Hordenine, Octopamine, Tyramine And N-Methyltyramine.

11 ) A composition as in claim 7 wherein said Alpha-2 Receptor Antagonist is Yohimbine.

12 ) A composition as in claim 7 wherein said Vinca Alkaloid is Vinpocetine.

13 ) A composition as in claim 7 wherein said administration comprises a therapeutically effective dosage.

14 ) The composition of claim 7 formulated for enteral administration comprising said unit dosage form admixed with flavors and sweeteners.

15 ) The composition of claim 7 formulated for enteral administration comprising said unit dosage form contained in blended powder or one or more capsules.

16 ) A composition according to claim 7 wherein said composition is in the form of a powder, tablet, capsule, pill, liquid, food additive, candy, confection or nutrition bar.

17 ) A composition according to claim 15 wherein said powder is admixed with a liquid.

18 ) The composition of claim 7 in a sustained release form.

19 ) An composition for enteral or parenteral administration comprising:

100 mg to about 500 mg by weight of Caffeine,

5 to 80 mg by weight of Adrenergic Amine,

5 mg to 100 mg by weight of Forskolin,

5 mg to 80 mg by weight of Guggulsterone,

5 mg to 50 mg by weight of Alpha-2 Receptor Antagonist, and

5 to 50 mg by weight of Vinca Alkaloid.

20 ) A method according to claim 1 , wherein administering is performed on a daily basis.

21 ) A method according to claim 19 , wherein said daily administration comprises at least two partial daily administrations of said composition.

22 ) A method according to claim 1 , wherein administering is performed following an exercise period.

23 ) A method according to claim 1 , wherein the composition comprises an amount of from about 125 mg to about 1310 g per day.

24 ) A method according to claim 1 , wherein the composition comprises an amount of about 270 mg to about 810 mg per day.

25 ) A method as in claim 1 wherein said administration comprises a single daily administration.

26 ) A method as in claim 1 wherein said administration comprises partial daily administration, said partial daily administrations comprising at least one nutrient selected from the group comprising Caffeine, Adrenergic Amine, Forskolin, Guggulsterone, Alpha-2 Receptor Antagonist, and Vinca Alkaloid.

27 ) An composition consisting essentially of: 74.10% Caffeine, 7.41% Synephrine, 7.41% Forskolin, 7.41% Guggulsterones, 1.84% Yohimbine, and 1.84% Vinpocetine.

28 ) A composition according to claim 7 wherein said compound weights are adjusted according to predetermined factors.

29 ) A composition according to claim 27 wherein said predetermined factors include an individual's weight.

30 ) A composition according to claim 27 wherein said predetermined factors include an individual's exercise intensity.

31 ) A composition according to claim 27 wherein said predetermined factors include an individual's lean body mass.

32 ) A composition according to claim 27 wherein said predetermined factors include an individual's proportion of body fat to lean body mass.

33 ) A composition according to claim 27 wherein said predetermined factors include an individual's desire to increase energy.

34 ) A composition according to claim 27 wherein said predetermined factors include an individual's desire to increase stamina.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2003
From: BOLDT, MATTHIAS
To: SAN CORPORATION
Reel/Frame 014833/0387 →